When systems integrate better, every minute saved by removing roadblocks is a minute given back to clinicians and patient care. It’s time for vendors in this space to treat interoperability as a core business strategy rather than a buzzword or another box to check as they’re going through the motions. The post Why Playing Nice…
[Sponsored] The ongoing nursing shortage facilitates high turnover rates since nurses know they won’t have difficulties finding new jobs. In order to retain and attract staff, it’s in a facility’s best interest to understand what nurses want. The post Changes in Nurse Staffing Answer Clinician Demands appeared first on MedCity News.
Enhancing the accessibility of trustworthy medicines information and the availability of SRDs while also improving search technologies will ensure HCPs can quickly obtain accurate answers to their specific questions. The post The Challenges Of HCPs Accessing Reliable Online Medicines Information and What Pharma Companies Can Do To Improve Information Sharing appeared first on MedCity News.
The annual growth rate of spending for traditional drugs increased from 2.1% in 2021 to 12.8% in 2024, according to Evernorth Research Institute. The post Report: Traditional Drug Costs Outpace Specialty Due to GLP-1 Demand appeared first on MedCity News.
The FDA approved GSK antibiotic Blujepa as a treatment for uncomplicated urinary tract infections. The drug’s novel mechanism of action addresses a broader range of pathogens and could offer a way to lower the potential for drug resistance. The post FDA Approves First-in-Class GSK Antibiotic for Common Type of Urinary Tract Infection appeared first on…
Finalists in the Pitch Perfect contest at INVEST, scheduled for May 20-21 in Chicago at the Willis Tower, span medtech for asthma, diabetic neuropathy, Parkinson’s disease, and more. Register today! The post Check Out the Future of Medtech: A Preview of Device and Diagnostics INVEST Pitch Perfect Finalists appeared first on MedCity News.
If marketing’s participation isn’t already incorporated into a company’s official product development process, they’re missing the boat. The post Marketing’s Untapped Opportunity in the Medical Product Lifecycle appeared first on MedCity News.
While high-acuity options must remain for those that need stronger interventions, millions more could be benefiting from access to low-acuity or minimal interventions. The post The Workforce is Suffering from Chronic Back Pain — It’s Time for a New Approach appeared first on MedCity News.
Apellis Pharmaceuticals and Astellas Pharma have the first two FDA-approved therapies for geographic atrophy, but Character Biosciences claims its approach could be best in class for treating this advanced form of dry age-related macular degeneration. The biotech’s Series B round will finance clinical tests of two programs, each addressing a different stage of the disease….
Navina closed a $55 million Series C funding round led by Goldman Sachs. The company, based in Israel and New York, uses AI to help primary care physicians thrive in value-based care models. The post Navina Snags $55M for Its Value-Based Care AI Copilot appeared first on MedCity News.